117 related articles for article (PubMed ID: 18812197)
1. Human CD8+ T-regulatory cells with low-avidity T-cell receptor specific for minor histocompatibility antigens.
Burlingham WJ; Goulmy E
Hum Immunol; 2008 Nov; 69(11):728-31. PubMed ID: 18812197
[TBL] [Abstract][Full Text] [Related]
2. Minor H antigen HA-1-specific regulator and effector CD8+ T cells, and HA-1 microchimerism, in allograft tolerance.
Cai J; Lee J; Jankowska-Gan E; Derks R; Pool J; Mutis T; Goulmy E; Burlingham WJ
J Exp Med; 2004 Apr; 199(7):1017-23. PubMed ID: 15067036
[TBL] [Abstract][Full Text] [Related]
3. Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members.
van Halteren AG; Jankowska-Gan E; Joosten A; Blokland E; Pool J; Brand A; Burlingham WJ; Goulmy E
Blood; 2009 Sep; 114(11):2263-72. PubMed ID: 19506299
[TBL] [Abstract][Full Text] [Related]
4. Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration.
Janicki CN; Jenkinson SR; Williams NA; Morgan DJ
Cancer Res; 2008 Apr; 68(8):2993-3000. PubMed ID: 18413769
[TBL] [Abstract][Full Text] [Related]
5. CD8+ effector T cells at the fetal-maternal interface, balancing fetal tolerance and antiviral immunity.
Tilburgs T; Strominger JL
Am J Reprod Immunol; 2013 Apr; 69(4):395-407. PubMed ID: 23432707
[TBL] [Abstract][Full Text] [Related]
6. The role and mechanisms of double negative regulatory T cells in the suppression of immune responses.
Chen W; Ford MS; Young KJ; Zhang L
Cell Mol Immunol; 2004 Oct; 1(5):328-35. PubMed ID: 16285891
[TBL] [Abstract][Full Text] [Related]
7. Isolation of human CD4/CD8 double-positive, graft-versus-host disease-protective, minor histocompatibility antigen-specific regulatory T cells and of a novel HLA-DR7-restricted HY-specific CD4 clone.
Eljaafari A; Yuruker O; Ferrand C; Farre A; Addey C; Tartelin ML; Thomas X; Tiberghien P; Simpson E; Rigal D; Scott D
J Immunol; 2013 Jan; 190(1):184-94. PubMed ID: 23225889
[TBL] [Abstract][Full Text] [Related]
8. CD8 T-cell ability to exert immunodomination correlates with T-cell receptor: epitope association rate.
Roy-Proulx G; Baron C; Perreault C
Biol Blood Marrow Transplant; 2005 Apr; 11(4):260-71. PubMed ID: 15812391
[TBL] [Abstract][Full Text] [Related]
9. Regulatory balance between the immune response of tumor antigen-specific T-cell receptor gene-transduced CD8 T cells and the suppressive effects of tolerogenic dendritic cells.
Fujii S; Nishimura MI; Lotze MT
Cancer Sci; 2005 Dec; 96(12):897-902. PubMed ID: 16367910
[TBL] [Abstract][Full Text] [Related]
10. CD8+ regulatory T cells-A distinct T-cell lineage or a transient T-cell phenotype?
Aandahl EM; Torgersen KM; Taskén K
Hum Immunol; 2008 Nov; 69(11):696-9. PubMed ID: 18817824
[TBL] [Abstract][Full Text] [Related]
11. Positive selection of self-antigen-specific CD8+ T cells by hematopoietic cells.
Yamada H; Shibata K; Sakuraba K; Fujimura K; Yoshikai Y
Eur J Immunol; 2013 Aug; 43(8):2033-42. PubMed ID: 23636825
[TBL] [Abstract][Full Text] [Related]
12. Use of HLA-B27 tetramers to identify low-frequency antigen-specific T cells in Chlamydia-triggered reactive arthritis.
Appel H; Kuon W; Kuhne M; Wu P; Kuhlmann S; Kollnberger S; Thiel A; Bowness P; Sieper J
Arthritis Res Ther; 2004; 6(6):R521-34. PubMed ID: 15535830
[TBL] [Abstract][Full Text] [Related]
13. Selection for survival?
Benoist C; Mathis D
Science; 1997 Jun; 276(5321):2000-1. PubMed ID: 9221508
[No Abstract] [Full Text] [Related]
14. Efficient induction and expansion of human alloantigen-specific CD8 regulatory T cells from naive precursors by CD40-activated B cells.
Zheng J; Liu Y; Qin G; Chan PL; Mao H; Lam KT; Lewis DB; Lau YL; Tu W
J Immunol; 2009 Sep; 183(6):3742-50. PubMed ID: 19684082
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo detection of CD8 T cells specific for H-Y minor histocompatibility antigens in allogeneic hematopoietic stem cell transplant recipients.
Nakamura R; La Rosa C; Tsai W; Lacey SF; Srivastava T; Seidel A; Senitzer D; Forman SJ; Diamond DJ
Transpl Immunol; 2014 May; 30(4):128-35. PubMed ID: 24582729
[TBL] [Abstract][Full Text] [Related]
16. Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28- T suppressor cells.
Scotto L; Naiyer AJ; Galluzzo S; Rossi P; Manavalan JS; Kim-Schulze S; Fang J; Favera RD; Cortesini R; Suciu-Foca N
Hum Immunol; 2004 Nov; 65(11):1297-306. PubMed ID: 15556680
[TBL] [Abstract][Full Text] [Related]
17. Multiple mechanisms of peripheral T cell tolerance to the fetal "allograft".
Jiang SP; Vacchio MS
J Immunol; 1998 Apr; 160(7):3086-90. PubMed ID: 9531261
[TBL] [Abstract][Full Text] [Related]
18. Long-term immune reconstitution and infection burden after mismatched hematopoietic stem cell transplantation.
Servais S; Lengline E; Porcher R; Carmagnat M; Peffault de Latour R; Robin M; Sicre de Fontebrune F; Clave E; Maki G; Granier C; Xhaard A; Dhedin N; Molina JM; Toubert A; Moins-Teisserenc H; Socie G
Biol Blood Marrow Transplant; 2014 Apr; 20(4):507-17. PubMed ID: 24406505
[TBL] [Abstract][Full Text] [Related]
19. Commentary: Priming of alloreactive T cells--where does it happen?
Golshayan D; Lechler R
Eur J Immunol; 2004 Dec; 34(12):3301-4. PubMed ID: 15484195
[TBL] [Abstract][Full Text] [Related]
20. Comparison of vaccine-induced effector CD8 T cell responses directed against self- and non-self-tumor antigens: implications for cancer immunotherapy.
Pedersen SR; Sørensen MR; Buus S; Christensen JP; Thomsen AR
J Immunol; 2013 Oct; 191(7):3955-67. PubMed ID: 24018273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]